185 related articles for article (PubMed ID: 12045454)
1. A3 adenosine receptor as a target for cancer therapy.
Fishman P; Bar-Yehuda S; Madi L; Cohn I
Anticancer Drugs; 2002 Jun; 13(5):437-43. PubMed ID: 12045454
[TBL] [Abstract][Full Text] [Related]
2. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
Fishman P; Bar-Yehuda S; Barer F; Madi L; Multani AS; Pathak S
Exp Cell Res; 2001 Oct; 269(2):230-6. PubMed ID: 11570815
[TBL] [Abstract][Full Text] [Related]
3. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
[TBL] [Abstract][Full Text] [Related]
4. Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents.
Bar-Yehuda S; Madi L; Barak D; Mittelman M; Ardon E; Ochaion A; Cohn S; Fishman P
Exp Hematol; 2002 Dec; 30(12):1390-8. PubMed ID: 12482500
[TBL] [Abstract][Full Text] [Related]
5. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
Fishman P; Bar-Yehuda S; Ardon E; Rath-Wolfson L; Barrer F; Ochaion A; Madi L
Anticancer Res; 2003; 23(3A):2077-83. PubMed ID: 12894581
[TBL] [Abstract][Full Text] [Related]
6. A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
Madi L; Bar-Yehuda S; Barer F; Ardon E; Ochaion A; Fishman P
J Biol Chem; 2003 Oct; 278(43):42121-30. PubMed ID: 12865431
[TBL] [Abstract][Full Text] [Related]
7. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
Mlejnek P; Dolezel P; Frydrych I
J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
[TBL] [Abstract][Full Text] [Related]
8. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis.
Gao Z; Li BS; Day YJ; Linden J
Mol Pharmacol; 2001 Jan; 59(1):76-82. PubMed ID: 11125027
[TBL] [Abstract][Full Text] [Related]
9. Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis.
Appel E; Kazimirsky G; Ashkenazi E; Kim SG; Jacobson KA; Brodie C
J Mol Neurosci; 2001 Dec; 17(3):285-92. PubMed ID: 11859924
[TBL] [Abstract][Full Text] [Related]
10. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
Fishman P; Bar-Yehuda S; Madi L; Rath-Wolfson L; Ochaion A; Cohen S; Baharav E
Arthritis Res Ther; 2006; 8(1):R33. PubMed ID: 16507132
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101.
Ohana G; Bar-Yehuda S; Arich A; Madi L; Dreznick Z; Rath-Wolfson L; Silberman D; Slosman G; Fishman P
Br J Cancer; 2003 Oct; 89(8):1552-8. PubMed ID: 14562031
[TBL] [Abstract][Full Text] [Related]
12. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
[TBL] [Abstract][Full Text] [Related]
13. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors.
Fishman P; Bar-Yehuda S; Farbstein T; Barer F; Ohana G
J Cell Physiol; 2000 Jun; 183(3):393-8. PubMed ID: 10797314
[TBL] [Abstract][Full Text] [Related]
14. A3 adenosine receptor agonist potentiates natural killer cell activity.
Harish A; Hohana G; Fishman P; Arnon O; Bar-Yehuda S
Int J Oncol; 2003 Oct; 23(4):1245-9. PubMed ID: 12964011
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.
Ohana G; Bar-Yehuda S; Barer F; Fishman P
J Cell Physiol; 2001 Jan; 186(1):19-23. PubMed ID: 11147810
[TBL] [Abstract][Full Text] [Related]
16. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.
Kim TH; Kim YK; Woo JS
Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643
[TBL] [Abstract][Full Text] [Related]
17. Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration.
Koszałka P; Gołuńska M; Urban A; Stasiłojć G; Stanisławowski M; Majewski M; Składanowski AC; Bigda J
PLoS One; 2016; 11(3):e0151420. PubMed ID: 26964090
[TBL] [Abstract][Full Text] [Related]
18. Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells.
Reshkin SJ; Guerra L; Bagorda A; Debellis L; Cardone R; Li AH; Jacobson KA; Casavola V
J Membr Biol; 2000 Nov; 178(2):103-13. PubMed ID: 11083899
[TBL] [Abstract][Full Text] [Related]
19. Induction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A3 adenosine receptor.
Palmer TM; Harris CA; Coote J; Stiles GL
Mol Pharmacol; 1997 Oct; 52(4):632-40. PubMed ID: 9380026
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells.
Nakashima KI; Iwao K; Inoue T; Haga A; Tsutsumi T; Mochita MI; Fujimoto T; Tanihara H
Exp Eye Res; 2018 May; 170():160-168. PubMed ID: 29486164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
